• Je něco špatně v tomto záznamu ?

Sepsis-mediated renal dysfunction: Pathophysiology, biomarkers and role of phytoconstituents in its management

A. Balkrishna, S. Sinha, A. Kumar, V. Arya, AK. Gautam, M. Valis, K. Kuca, D. Kumar, R. Amarowicz

. 2023 ; 165 (-) : 115183. [pub] 20230722

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016349

Sepsis has evolved as an enormous health issue amongst critically ill patients. It is a major risk factor that results in multiple organ failure and shock. Acute kidney injury (AKI) is one of the most frequent complications underlying sepsis, which portends a heavy burden of mortality and morbidity. Thus, the present review is aimed to provide an insight into the recent progression in the molecular mechanisms targeting dysregulated immune response and cellular dysfunction involved in the development of sepsis-associated AKI, accentuating the phytoconstituents as eligible candidates for attenuating the onset and progression of sepsis-associated AKI. The pathogenesis of sepsis-mediated AKI entails a complicated mechanism and is likely to involve a distinct constellation of hemodynamic, inflammatory, and immune mechanisms. Novel biomarkers like neutrophil gelatinase-associated lipocalin, soluble triggering receptor expressed on myeloid cells 1, procalcitonin, alpha-1-microglobulin, and presepsin can help in a more sensitive diagnosis of sepsis-associated AKI. Many bioactive compounds like curcumin, resveratrol, baicalin, quercetin, and polydatin are reported to play an important role in the prevention and management of sepsis-associated AKI by decreasing serum creatinine, blood urea nitrogen, cystatin C, lipid peroxidation, oxidative stress, IL-1β, TNF-α, NF-κB, and increasing the activity of antioxidant enzymes and level of PPARγ. The plant bioactive compounds could be developed into a drug-developing candidate in managing sepsis-mediated acute kidney injury after detailed follow-up studies. Lastly, the gut-kidney axis may be a more promising therapeutic target against the onset of septic AKI, but a deeper understanding of the molecular pathways is still required.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016349
003      
CZ-PrNML
005      
20231026110009.0
007      
ta
008      
231013s2023 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.biopha.2023.115183 $2 doi
035    __
$a (PubMed)37487442
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Balkrishna, Acharya $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India
245    10
$a Sepsis-mediated renal dysfunction: Pathophysiology, biomarkers and role of phytoconstituents in its management / $c A. Balkrishna, S. Sinha, A. Kumar, V. Arya, AK. Gautam, M. Valis, K. Kuca, D. Kumar, R. Amarowicz
520    9_
$a Sepsis has evolved as an enormous health issue amongst critically ill patients. It is a major risk factor that results in multiple organ failure and shock. Acute kidney injury (AKI) is one of the most frequent complications underlying sepsis, which portends a heavy burden of mortality and morbidity. Thus, the present review is aimed to provide an insight into the recent progression in the molecular mechanisms targeting dysregulated immune response and cellular dysfunction involved in the development of sepsis-associated AKI, accentuating the phytoconstituents as eligible candidates for attenuating the onset and progression of sepsis-associated AKI. The pathogenesis of sepsis-mediated AKI entails a complicated mechanism and is likely to involve a distinct constellation of hemodynamic, inflammatory, and immune mechanisms. Novel biomarkers like neutrophil gelatinase-associated lipocalin, soluble triggering receptor expressed on myeloid cells 1, procalcitonin, alpha-1-microglobulin, and presepsin can help in a more sensitive diagnosis of sepsis-associated AKI. Many bioactive compounds like curcumin, resveratrol, baicalin, quercetin, and polydatin are reported to play an important role in the prevention and management of sepsis-associated AKI by decreasing serum creatinine, blood urea nitrogen, cystatin C, lipid peroxidation, oxidative stress, IL-1β, TNF-α, NF-κB, and increasing the activity of antioxidant enzymes and level of PPARγ. The plant bioactive compounds could be developed into a drug-developing candidate in managing sepsis-mediated acute kidney injury after detailed follow-up studies. Lastly, the gut-kidney axis may be a more promising therapeutic target against the onset of septic AKI, but a deeper understanding of the molecular pathways is still required.
650    _2
$a lidé $7 D006801
650    _2
$a lipokaliny $x terapeutické užití $7 D054834
650    _2
$a proteiny akutní fáze $x analýza $x metabolismus $x terapeutické užití $7 D000209
650    12
$a sepse $x komplikace $x farmakoterapie $7 D018805
650    12
$a akutní poškození ledvin $x farmakoterapie $x etiologie $x diagnóza $7 D058186
650    _2
$a biologické markery $7 D015415
650    _2
$a peptidové fragmenty $x metabolismus $7 D010446
650    _2
$a lipopolysacharidové receptory $x metabolismus $7 D018950
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Sinha, Sugandh $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India
700    1_
$a Kumar, Ashwani $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India. Electronic address: dr.ashwanikumar@patanjali.res.in
700    1_
$a Arya, Vedpriya $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India
700    1_
$a Gautam, Ajay Kumar $u Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India
700    1_
$a Valis, Martin $u Department of Neurology, Charles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital, Hradec Králové, Czech Republic
700    1_
$a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital in Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic. Electronic address: kamil.kuca@uhk.cz
700    1_
$a Kumar, Dinesh $u School of Bioengineering and Food Technology, Shoolini University of Biotechnology and Management Sciences, Solan, India
700    1_
$a Amarowicz, Ryszard $u Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland
773    0_
$w MED00005486 $t Biomedicine & pharmacotherapy Biomedecine & pharmacotherapie $x 1950-6007 $g Roč. 165, č. - (2023), s. 115183
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37487442 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110003 $b ABA008
999    __
$a ok $b bmc $g 2000082 $s 1202711
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 165 $c - $d 115183 $e 20230722 $i 1950-6007 $m Biomedicine & pharmacotherapy $n Biomed Pharmacother $x MED00005486
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...